<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T22:30:39Z</responseDate>
  <request identifier="oai:figshare.com:article/34017577" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34017577</identifier>
        <datestamp>2026-09-28T17:52:12Z</datestamp>
        <setSpec>category_12</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_69</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Targeting SVCV G palmitoylation with a peptide inhibitor.&lt;/p&gt;</dc:title>
          <dc:creator>Chen Li (54018)</dc:creator>
          <dc:creator>Yan Zhang (8098)</dc:creator>
          <dc:creator>Yujun Zhang (118792)</dc:creator>
          <dc:creator>Yan Gao (93649)</dc:creator>
          <dc:creator>Yuanan Lu (324035)</dc:creator>
          <dc:creator>Shengbo Cao (105106)</dc:creator>
          <dc:creator>Jing Ye (94291)</dc:creator>
          <dc:creator>Xueqin Liu (494581)</dc:creator>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Inorganic Chemistry</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>significant economic impacts</dc:subject>
          <dc:subject>pathogenicity remain unclear</dc:subject>
          <dc:subject>modification enhances stability</dc:subject>
          <dc:subject>hold broader significance</dc:subject>
          <dc:subject>employed spring viremia</dc:subject>
          <dc:subject>competitive peptide targeting</dc:subject>
          <dc:subject>cell membrane localization</dc:subject>
          <dc:subject>20 &amp;# 176</dc:subject>
          <dc:subject>molecular mechanisms underlying</dc:subject>
          <dc:subject>affects rhabdovirus infections</dc:subject>
          <dc:subject>temperature adaptive evolution</dc:subject>
          <dc:subject>rhabdovirus prevalent</dc:subject>
          <dc:subject>mechanism underlying</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>svcv glycoprotein</dc:subject>
          <dc:subject>svcv ),</dc:subject>
          <dc:subject>similar mechanism</dc:subject>
          <dc:subject>palmitic acid</dc:subject>
          <dc:subject>numerous rhabdoviruses</dc:subject>
          <dc:subject>high infectivity</dc:subject>
          <dc:subject>global aquaculture</dc:subject>
          <dc:subject>g protein</dc:subject>
          <dc:subject>g ).</dc:subject>
          <dc:subject>findings elucidate</dc:subject>
          <dc:subject>dependent infectivity</dc:subject>
          <dc:subject>crucial factor</dc:subject>
          <dc:subject>carp virus</dc:subject>
          <dc:subject>c ),</dc:subject>
          <dc:subject>aquatic rhabdoviruses</dc:subject>
          <dc:subject>acyltransferase zdhhc15a</dc:subject>
          <dc:description>&lt;p&gt;&lt;b&gt;(A)&lt;/b&gt; Schematic of CPP-GS1 and CPP-GS2 peptides. The different residues are shown in red. CPPtat, CPP from HIV-1 Tat protein. &lt;b&gt;(B)&lt;/b&gt; ZF4 cells were transfected with SVCV G for 6 h and then were incubated of CPPtat-GS1 and CPPtat-GS2 for 18 &lt;b&gt;h.&lt;/b&gt; IP-ABE detection of palmitoylation of SVCV G in ZF4 cells. &lt;b&gt;(C)&lt;/b&gt; ZF4 cells were transfected with SVCV G for 6 h and then were incubated of CPPtat-GS1 and CPPtat-GS2 for 18 &lt;b&gt;h.&lt;/b&gt; Then, the cells were analyzed for SVCV G expression. &lt;b&gt;(D-E)&lt;/b&gt; ZF4 cells were infected with SVCV G for 6 h and then were incubated of CPPtat-GS1 and CPPtat-GS2 for 18 &lt;b&gt;h.&lt;/b&gt; Cell samples and supernatant were collected 24 h after infection. The viral RNA abundance was detected using qRT-PCR. SVCV titers were measured by Viral plaque assay. &lt;b&gt;(F-G)&lt;/b&gt; ZF4 cells were infected with SVCV for 6 h and then were incubated with different concentrations of CPPtat-GS1 for 18 &lt;b&gt;h.&lt;/b&gt; Cell samples and supernatant were collected 24 h after infection. The viral RNA abundance was detected using qRT-PCR. SVCV titers were measured by Viral plaque assay. &lt;b&gt;(H)&lt;/b&gt; Zebrafish, with an average body weight of 0.6 &lt;b&gt;g.&lt;/b&gt; At 6 h post-infection with 10&lt;sup&gt;4&lt;/sup&gt; PFU SVCV, zebrafish were divided into distinct treatment groups (n = 30) and administered either DMSO or the CPP-GS1 peptide (50mg/kg). The survival rate of the zebrafish was subsequently assessed 14 days post-injection. Statistics of survival rate were calculated with the log-rank (Mantel-Cox). ***&lt;i&gt;p&lt;/i&gt; &lt; 0.001. &lt;b&gt;(I)&lt;/b&gt; The virus titer of SVCV at 5 dpi from the spleen, intestine, and brain after CPP-GS1 administration (n = 3 zebrafish per group). Data was presented as mean ± SD from three independent experiments. Statistical analysis was performed using Student’s &lt;i&gt;t&lt;/i&gt;-&lt;i&gt;t&lt;/i&gt;est and one-way ANOVA between different groups and the asterisk (*) indicates significant differences between groups*&lt;i&gt;p&lt;/i&gt; &lt; 0.05, **&lt;i&gt;p&lt;/i&gt; &lt; 0.01, ***&lt;i&gt;p&lt;/i&gt; &lt; 0.001.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T17:51:51Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.ppat.1014654.g005</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Targeting_SVCV_G_palmitoylation_with_a_peptide_inhibitor_p_/34017577</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
